These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7615010)

  • 21. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor.
    Vargas SJ; Naprta A; Glaccum M; Lee SK; Kalinowski J; Lorenzo JA
    J Bone Miner Res; 1996 Nov; 11(11):1736-44. PubMed ID: 8915781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
    Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin.
    Kayama F; Yoshida T; Kodama Y; Matsui T; Matheson JM; Luster MI
    Cytokine; 1997 Sep; 9(9):688-95. PubMed ID: 9325018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition.
    Butler DM; Malfait AM; Mason LJ; Warden PJ; Kollias G; Maini RN; Feldmann M; Brennan FM
    J Immunol; 1997 Sep; 159(6):2867-76. PubMed ID: 9300710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin.
    Hawkins DL; Cargile JL; MacKay RJ; Broome TA; Skelley LA
    Am J Vet Res; 1995 Oct; 56(10):1292-9. PubMed ID: 8928945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Horai R; Nakajima A; Habiro K; Kotani M; Nakae S; Matsuki T; Nambu A; Saijo S; Kotaki H; Sudo K; Okahara A; Tanioka H; Ikuse T; Ishii N; Schwartzberg PL; Abe R; Iwakura Y
    J Clin Invest; 2004 Dec; 114(11):1603-11. PubMed ID: 15578092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.
    Sugihara T; Okiyama N; Watanabe N; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2012 Aug; 64(8):2655-62. PubMed ID: 22392010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice.
    McNamara MJ; Norton JA; Nauta RJ; Alexander HR
    J Surg Res; 1993 Apr; 54(4):316-21. PubMed ID: 8331925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
    Schett G; Redlich K; Hayer S; Zwerina J; Bolon B; Dunstan C; Görtz B; Schulz A; Bergmeister H; Kollias G; Steiner G; Smolen JS
    Arthritis Rheum; 2003 Jul; 48(7):2042-51. PubMed ID: 12847699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor.
    Piguet PF; Grau GE; Vesin C; Loetscher H; Gentz R; Lesslauer W
    Immunology; 1992 Dec; 77(4):510-4. PubMed ID: 1337334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
    Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
    Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-beta expression in the joint.
    Marinova-Mutafchieva L; Gabay C; Funa K; Williams RO
    Clin Exp Immunol; 2006 Nov; 146(2):287-93. PubMed ID: 17034581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis.
    Hayer S; Redlich K; Korb A; Hermann S; Smolen J; Schett G
    Arthritis Rheum; 2007 Jan; 56(1):79-88. PubMed ID: 17195210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
    J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.
    Edwards CK; Bendele AM; Reznikov LI; Fantuzzi G; Chlipala ES; Li L; Moldawer LL; Mountz JD; Li YY; Dinarello CA
    Arthritis Rheum; 2006 Sep; 54(9):2872-85. PubMed ID: 16947419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
    Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K
    J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis.
    Hayer S; Niederreiter B; Nagelreiter I; Smolen J; Redlich K
    Ann Rheum Dis; 2010 Jul; 69(7):1403-6. PubMed ID: 20498200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.